Flerie

27.20 SEK

+2.64%

Less than 1K followers

FLERIE

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Flerie

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Revenue0.1
EBITDA-82.2-274.2-181.0167.2-146.7-538.8-699.5-62.9
EBIT-82.5-275.0-181.2167.0-146.9-539.0-700.1-63.0
EBIT-%-275,000.0 %
Profit before taxes-60.0-227.9-257.5174.2-135.9-538.7-757.9-61.5
Net income-64.0-228.0-251.0173.5-138.5-540.9-756.9-61.5